Haddad R - Search Results

1

Management of treatment-related toxicities in advanced medullary thyroid cancer.

Brose MS, Bible KC, Chow LQM, Gilbert J, Grande C, Worden F, Haddad R. Brose MS, et al. Among authors: haddad r. Cancer Treat Rev. 2018 May;66:64-73. doi: 10.1016/j.ctrv.2018.04.007. Epub 2018 Apr 22. Cancer Treat Rev. 2018. PMID: 29704768 Review.

2

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.

Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Haddad R, et al. Cancer. 2003 Jan 15;97(2):412-8. doi: 10.1002/cncr.11063. Cancer. 2003. PMID: 12518365 Free article.

3

Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.

Haddad RI, Wirth L, Posner MR. Haddad RI, et al. Expert Rev Anticancer Ther. 2003 Jun;3(3):331-8. doi: 10.1586/14737140.3.3.331. Expert Rev Anticancer Ther. 2003. PMID: 12820776 Review.

4

Emerging drugs for head and neck cancer.

Haddad R, Wirth L, Posner M. Haddad R, et al. Expert Opin Emerg Drugs. 2006 Sep;11(3):461-7. doi: 10.1517/14728214.11.3.461. Expert Opin Emerg Drugs. 2006. PMID: 16939385 Review.

5

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB. Haddad R, et al. Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525. Cancer. 2009. PMID: 19634161 Free article. Clinical Trial.

6

Vandetanib for the treatment of medullary thyroid cancer.

Chau NG, Haddad RI. Chau NG, et al. Clin Cancer Res. 2013 Feb 1;19(3):524-9. doi: 10.1158/1078-0432.CCR-12-2353. Epub 2012 Dec 11. Clin Cancer Res. 2013. PMID: 23231950 Review.

7

New developments in thyroid cancer.

Haddad RI. Haddad RI. J Natl Compr Canc Netw. 2013 May;11(5 Suppl):705-7. doi: 10.6004/jnccn.2013.0207. J Natl Compr Canc Netw. 2013. PMID: 23704249 Review.

8

How to incorporate new tyrosine kinase inhibitors in the treatment of patients with medullary thyroid cancer.

Haddad RI. Haddad RI. J Clin Oncol. 2013 Oct 10;31(29):3618-20. doi: 10.1200/JCO.2013.51.5098. Epub 2013 Sep 3. J Clin Oncol. 2013. PMID: 24002516 No abstract available.

9

Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA. Limaye SA, et al. Cancer. 2013 Dec 15;119(24):4268-76. doi: 10.1002/cncr.28365. Epub 2013 Sep 24. Cancer. 2013. PMID: 24114811 Free article. Clinical Trial.

10

Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions.

Schmitz S, Ang KK, Vermorken J, Haddad R, Suarez C, Wolf GT, Hamoir M, Machiels JP. Schmitz S, et al. Among authors: haddad r. Cancer Treat Rev. 2014 Apr;40(3):390-404. doi: 10.1016/j.ctrv.2013.09.007. Epub 2013 Sep 14. Cancer Treat Rev. 2014. PMID: 24176789 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,202 results

Search Page